GlassScriptPhysician profile
David James Hoyt
NPI 1548256423
$1,065.60
in general payments reported to CMS, 2019-2025
14 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $23.84 · 2022: $26.14 · 2023: $151 · 2024: $132 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.82 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $162.56 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $138.97 | 2019-2022 | |
| Glaxosmithkline, LLC. | $131.91 | 2024-2025 | Nucala |
| Acclarent, INC | $131.34 | 2019-2024 | Trudi Nav Cable |
| Genzyme Corporation | $119.83 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $98.00 | 2023 | |
| Intersect Ent, INC. | $96.00 | 2019 | |
| Integra Lifesciences Corporation | $87.42 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Smith+Nephew, INC. | $23.84 | 2020 | |
| Hologic Sales and Service, LLC | $18.67 | 2025 | Coolseal Generator |
| Hikma Pharmaceuticals USA | $16.03 | 2024 | Ryaltris |
| Merck Sharp & Dohme LLC | $16.00 | 2023 | |
| Optinose US, INC. | $14.03 | 2019 | |
| Glenmark Therapeutics INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hoyt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.